Ken Getz, assistant professor at Tufts Center for the Study of Drug Development (CSDD), reports that oftentimes procedures performed in the last drug development stages are in order to find “supplementary, secondary, tertiary, and exploratory endpoints.”...
On October 14, the 7th Annual Site Solutions Summit announced the formation of a new association focusing on the needs and challenges of the research site. President of The Society for Clinical Research Sites (SCRS), Christine Pierre is aiming to “provide...
The Coalition For Accelerating Standards and Therapies (CFAST) was introduced at the CDISC International Interchange in Baltimore October 22-26. By congregating experts from each industry, data standards are expected to be maintained and developed. The coalition...
The Presidential Commission for the Study of Bioethical Issues, a government advisory panel, released a statement reinforcing the need for privacy protection for those who choose to submit their whole genome sequencing for the purpose of medical research. Genomes...
A recent article by Canadian Medical Association Journal discusses how the Helsinki doctrine is under review. The World Medical Association will revise the Declaration of Helsinki before the famous doctrine celebrates its 50th anniversary in 2014. Revisions are not...
FierceBiotech has compiled a list of the 20 top pharma-academic collaborations from 2012 which can be found here. This list notes the Big Pharma players who have collaborated with universities and academic medical centers and gone above and beyond typical research...
